HCPCS Level II · Drugs administered other than oral method
J1072Injection, testosterone cypionate (azmiro), 1 mg
✓ Active
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J1072
J1072 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing injection, testosterone cypionate (azmiro), 1 mg.
It was added to HCPCS effective 04/01/2025.
Its Medicare coverage code is "D", meaning special Medicare coverage instructions apply.
Details
- Short description
- Inj, testosterone, azmiro
- Date added
- 04/01/2025
- Action effective
- 04/01/2025
- BETOS
- O1E
Related J10xx codes
- J1000Injection, depo-estradiol cypionate, up to 5 mg
- J1010Injection, methylprednisolone acetate, 1 mg
- J1050Injection, medroxyprogesterone acetate, 1 mg
- J1071Injection, testosterone cypionate, 1 mg
- J1073Testosterone pellet, implant, 75 mg
- J1095Injection, dexamethasone 9 percent, intraocular, 1 microgram
- J1096Dexamethasone, lacrimal ophthalmic insert, 0.1 mg
- J1097Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml
- J1098Articaine ophthalmic, 8% solution, 0.4 ml
Common questions about J1072
Is HCPCS J1072 still valid?
- Yes. J1072 is active in the CMS October 2026 HCPCS file.
Does Medicare cover J1072?
- Its coverage code is "D": special Medicare coverage instructions apply. Check the local coverage determination for your region.